Haemostatic Gel Prophylaxis for Post Colorectal Endoscopic Resection Bleeding: Observational Study

Not Applicable

Recruiting

• Conditions: Colorectal advanced mucosal neoplasia; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Cancer - Bowel - Back passage (rectum) or large bowel (colon)

• Registration Number: ACTRN12620000245998
• Lead Sponsor: iverpool Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-26
• Last Update Posted: 5 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Colorectal lesions
Size 20mm and above
3 or less lesions per patient
Single agent (excluding aspirin) or multiple anti-thrombotic agent use ceased within 1 week before the procedure and resumed within 5 days after EMR

Exclusion Criteria

•Unable to provide informed consent
•Age <18 years old
•Pregnant
•Allergy to Purastat
•Cold” endoscopic mucosal resection

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of clinically significant post-procedural bleeding requiring further intervention (such as blood transfusion, admission to hospital, or other blood products (such as platelets, fresh frozen plasma, prothrombinex)<br>This will be assessed clinically by the presence of gastrointestinal bleeding (such as per-rectal bleeding) where patients were given blood products as documented in the medical record.[ 30 days post endoscopic procedure]